{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:11:32Z","timestamp":1792894292696,"version":"4.5.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Cohortes-Investissements d\u2019Avenir","award":["ANR-IA-COH-2012\/3731"],"award-info":[{"award-number":["ANR-IA-COH-2012\/3731"]}]},{"DOI":"10.13039\/501100004562","name":"Ministry of Higher Education and Research","doi-asserted-by":"publisher","award":["2023-1322"],"award-info":[{"award-number":["2023-1322"]}],"id":[{"id":"10.13039\/501100004562","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hospital Clinical Research Program"},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014089","name":"Boehringer Ingelheim France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015699","name":"Fresenius Medical Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015699","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The Kidney Failure Risk Equation (KFRE) is a widely used tool to estimate the 2- and 5-year risk of progression to kidney failure in patients with chronic kidney disease (CKD). The choice of estimated glomerular filtration rate (eGFR) equation and biomarker may influence its prognostic performance. We aimed at comparing the predictive performance of the KFRE when used with different eGFR equations [CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) vs. EKFC (European Kidney Function Consortium)] and biomarkers (creatinine, cystatin C, or both) in a large French CKD cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed 2168 patients with CKD stages G3\u2013G5 from the prospective Chronic Kidney Disease Renal Epidemiology and Information Network cohort. Eight eGFR equations were evaluated in combination with both the four- and eight-variable KFRE models. Prognostic performance was assessed at 2 and 5 years using the time-dependent area under the receiver operating characteristic curve (AUROC), Brier scores, calibration plots, and decision curve analysis. Subgroup analyses were performed by age and sex.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Discrimination was uniformly high (AUROC\u00a0&amp;gt;\u00a00.89), but calibration patterns and decision curve analyses differed between equations. The creatinine-based CKD-EPI 2009 equation demonstrated robust and consistent performance across models and time horizons. EKFC equations\u2014especially when using creatinine alone\u2014showed slightly improved clinical utility at the 40% decision threshold. Cystatin C-based equations did not improve KFRE predictions compared to creatinine-based ones.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this French CKD cohort, both CKD-EPI 2009 and EKFC creatinine-based equations supported accurate risk prediction using the KFRE. These findings support the use of EKFC in European clinical practice and reinforce the importance of aligning eGFR equations with the population context when applying prognostic models.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ckj\/sfag097","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:45:37Z","timestamp":1773924337000},"source":"Crossref","is-referenced-by-count":3,"title":["Which equation and which biomarker should be used in the Kidney Failure Risk Equation? A comparative analysis in the CKD-REIN cohort"],"prefix":"10.1093","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0178-7389","authenticated-orcid":false,"given":"Antoine","family":"Lanot","sequence":"first","affiliation":[{"name":"Normandie Univ, UNICAEN, CHU de Caen Normandie, N\u00e9phrologie , Caen ,","place":["France"]},{"name":"Normandie universit\u00e9, Unicaen, UFR de m\u00e9decine , 2 rue des rochambelles, Caen ,","place":["France"]},{"name":"\u201cANTICIPE\u201d U1086 INSERM-UCN, Centre Fran\u00e7ois Baclesse , Caen ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1480-5761","authenticated-orcid":false,"given":"Pierre","family":"Delanaye","sequence":"additional","affiliation":[{"name":"University of Li\u00e8ge, CHU Sart Tilman Department of Nephrology\u2013Dialysis\u2013Transplantation, , Li\u00e8ge ,","place":["Belgium"]},{"name":"H\u00f4pital Universitaire Car\u00e9meau, Universit\u00e9 de Montpellier Department of Nephrology\u2013Dialysis\u2013Apheresis, , N\u00eemes ,","place":["France"]},{"name":"GIGA Metabolism and Cardiovascular Biology, University of Li\u00e8ge , Li\u00e8ge ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Metzger","sequence":"additional","affiliation":[{"name":"Paris Saclay University, Paris-Sud Univ, UVSQ, CESP, INSERM, Renal and Cardiovascular Epidemiology Team , Villejuif ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aghiles","family":"Hamroun","sequence":"additional","affiliation":[{"name":"Lille University Hospital Center, Lille University, Maison R\u00e9gionale de la Recherche Clinique, CHU Lille Department of Public Health-Epidemiology, , 6 Rue du Professeur Laguesse, Lille ,","place":["France"]},{"name":"INSERM, UMR1167, Risk Factors and Molecular Determinants of Aging-Related Disease (RID-AGE), Pasteur Institute of Lille, Lille University , Lille ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0438-6487","authenticated-orcid":false,"given":"Natalia","family":"Alencar\u00a0de\u00a0Pinho","sequence":"additional","affiliation":[{"name":"Paris Saclay University, Paris-Sud Univ, UVSQ, CESP, INSERM, Renal and Cardiovascular Epidemiology Team , Villejuif ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Mariat","sequence":"additional","affiliation":[{"name":"Service de Nephrologie, Dialyse et Transplantation Renale, Hopital Nord, CHU de Saint-Etienne , 25 Boulevard Pasteur, Saint-Etienne Cedex 2 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"2026042108121695200_bib1","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1001\/jama.2011.451","article-title":"A predictive model for progression of chronic kidney disease to kidney failure","volume":"305","author":"Tangri","year":"2011","journal-title":"JAMA"},{"key":"2026042108121695200_bib2","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1001\/jama.2015.18202","article-title":"CKD Prognosis Consortium. Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis","volume":"315","author":"Tangri","year":"2016","journal-title":"JAMA"},{"key":"2026042108121695200_bib3","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1038\/ki.2010.550","article-title":"Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts","volume":"79","author":"Astor","year":"2011","journal-title":"Kidney Int"},{"key":"2026042108121695200_bib4","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2026042108121695200_bib5","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","journal-title":"Kidney Int"},{"key":"2026042108121695200_bib6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"CKD-EPI Investigators. Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med"},{"key":"2026042108121695200_bib7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/ndt\/gfac241","article-title":"Performance of creatinine-based equations to estimate glomerular filtration rate in White and Black populations in Europe, Brazil and Africa","volume":"38","author":"Delanaye","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"2026042108121695200_bib8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.7326\/M20-4366","article-title":"Development and validation of a modified full age spectrum creatinine-based equation to estimate glomerular filtration rate: a cross-sectional analysis of pooled data","volume":"174","author":"Pottel","year":"2021","journal-title":"Ann Intern Med"},{"key":"2026042108121695200_bib9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1056\/NEJMoa2203769","article-title":"Cystatin C-based equation to estimate GFR without the inclusion of race and sex","volume":"388","author":"Pottel","year":"2023","journal-title":"N Engl J Med"},{"key":"2026042108121695200_bib10","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1515\/cclm-2024-1082","article-title":"EFLM Task Group on Chronic Kidney Disease. Recommendations for European laboratories based on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"63","author":"Cavalier","year":"2024","journal-title":"Clin Chem Lab Med"},{"key":"2026042108121695200_bib11","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJMoa1214234","article-title":"CKD Prognosis Consortium. Cystatin C versus creatinine in determining risk based on kidney function","volume":"369","author":"Shlipak","year":"2013","journal-title":"N Engl J Med"},{"key":"2026042108121695200_bib12","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"2026042108121695200_bib13","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1093\/ndt\/gft388","article-title":"The French Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort study","volume":"29","author":"Stengel","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"2026042108121695200_bib14","doi-asserted-by":"publisher","first-page":"426","DOI":"10.7326\/M20-0529","article-title":"Chronic Kidney Disease Prognosis Consortium. Conversion of urine protein-creatinine ratio or urine dipstick protein to urine albumin-creatinine ratio for use in chronic kidney disease screening and prognosis: an individual participant-based meta-analysis","volume":"173","author":"Sumida","year":"2020","journal-title":"Ann Intern Med"},{"key":"2026042108121695200_bib15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1515\/cclm-2022-0928","article-title":"The new, race-free, Chronic Kidney Disease Epidemiology Consortium (CKD-EPI) equation to estimate glomerular filtration rate: is it applicable in Europe? A position statement by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)","volume":"61","author":"Delanaye","year":"2022","journal-title":"Clin Chem Lab Med"},{"key":"2026042108121695200_bib16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ndt\/gfac254","article-title":"What should European nephrology do with the new CKD-EPI equation?","volume":"38","author":"Gansevoort","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"2026042108121695200_bib17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/ndt\/gfac197","article-title":"Removing race from the CKD-EPI equation and its impact on prognosis in a predominantly White European population","volume":"38","author":"Fu","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"2026042108121695200_bib18","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1093\/ckj\/sfad039","article-title":"New and old GFR equations: a European perspective","volume":"16","author":"Delanaye","year":"2023","journal-title":"Clin Kidney J"},{"key":"2026042108121695200_bib19","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1471-2288-13-152","article-title":"Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome","volume":"13","author":"Royston","year":"2013","journal-title":"BMC Med Res Methodol"},{"key":"2026042108121695200_bib20","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1002\/sim.5958","article-title":"Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks","volume":"32","author":"Blanche","year":"2013","journal-title":"Stat Med"},{"key":"2026042108121695200_bib21","doi-asserted-by":"publisher","first-page":"e074819","DOI":"10.1136\/bmj-2023-074819","article-title":"Evaluation of clinical prediction models (part 1): from development to external validation","volume":"384","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"2026042108121695200_bib22","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/S0895-4356(01)00341-9","article-title":"Internal validation of predictive models: efficiency of some procedures for logistic regression analysis","volume":"54","author":"Steyerberg","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"2026042108121695200_bib23","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/bimj.200610301","article-title":"Consistent estimation of the expected Brier score in general survival models with right-censored event times","volume":"48","author":"Gerds","year":"2006","journal-title":"Biometrical J"},{"key":"2026042108121695200_bib24","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making"},{"key":"2026042108121695200_bib25","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"2026042108121695200_bib26","doi-asserted-by":"publisher","first-page":"e1002955","DOI":"10.1371\/journal.pmed.1002955","article-title":"The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: an external validation and clinical impact projection cohort study","volume":"16","author":"Major","year":"2019","journal-title":"PLoS Med"},{"key":"2026042108121695200_bib27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1093\/ndt\/gfaf128","article-title":"Risk-based referral model to nephrologist-specialist care in Stockholm","volume":"41","author":"Caldinelli","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"2026042108121695200_bib28","doi-asserted-by":"publisher","first-page":"sfaf258","DOI":"10.1093\/ckj\/sfaf258","article-title":"Kidney Failure Risk Equation performance according to the etiology of chronic kidney disease in the CKD-CAREMEAU cohort","volume":"18","author":"Prouvot","year":"2025","journal-title":"Clin Kidney J"},{"key":"2026042108121695200_bib29","doi-asserted-by":"publisher","first-page":"e853","DOI":"10.1016\/S2589-7500(22)00188-1","article-title":"Interpreting area under the receiver operating characteristic curve","volume":"4","author":"de\u00a0Hond","year":"2022","journal-title":"Lancet Digital Health"},{"key":"2026042108121695200_bib30","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12916-019-1466-7","article-title":"Calibration: the Achilles heel of predictive analytics","volume":"17","author":"Van\u00a0Calster","year":"2019","journal-title":"BMC Med"},{"key":"2026042108121695200_bib31","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1001\/jama.2017.12126","article-title":"Discrimination and calibration of clinical prediction models: users\u2019 guides to the medical literature","volume":"318","author":"Alba","year":"2017","journal-title":"JAMA"},{"key":"2026042108121695200_bib32","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1681\/ASN.0000000000000050","article-title":"The Kidney Failure Risk Equation: evaluation of novel input variables including eGFR estimated using the CKD-EPI 2021 equation in 59 cohorts","volume":"34","author":"Grams","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"2026042108121695200_bib33","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ekir.2024.01.039","article-title":"Implications of implementing the 2021 CKD-EPI equation without race on managing patients with kidney disease in British Columbia","volume":"9","author":"Atiquzzaman","year":"2024","journal-title":"Kidney Int Rep"},{"key":"2026042108121695200_bib34","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.ekir.2025.01.030","article-title":"Discordant results between creatinine- and cystatin C-based equations for estimating GFR","volume":"10","author":"Delanaye","year":"2025","journal-title":"Kidney Int Rep"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfag097\/67433967\/sfag097.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/4\/sfag097\/68121040\/sfag097.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/4\/sfag097\/68121040\/sfag097.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T12:12:26Z","timestamp":1776773546000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfag097\/8530528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfag097","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,3,20]]},"article-number":"sfag097"}}